Tomotherapy comes as a boon for cancer treatment since it has a higher degree of precision, speed and accuracy.
Patients find it more comfortable to be treated under this technology owing to the rotational helical mechanism, also the set-up time is lesser as compared to other therapies.
"The launch of the most advanced version of the Tomotherapy technology is truly a remarkable development in the field of Radiation Oncology. This will be a revolutionary step in the treatment of cancer. With this system we can deliver both fractionated radiotherapy as well as SBRT and Radiosurgery," said Suneeta Reddy, Managing Director, Apollo Hospitals Group.
"The new generation radiation machine and our highly experienced team enables us to move ahead towards precise and personalised care, therefore improving the quality of life of cancer patients and ensure better clinical outcomes," Reddy added.
Tomotherapy is effective in treating cancer, irrespective of the stage, especially multiple metastasis.
The best outcomes are for treatment of bilateral breast cancer, paediatric oncology and all other forms of cancer.
"We are taking precision and excellence to the next level with the revolutionary Radixact-X9: Tomotherapy, system powered by state-of-the-art 3D CT imaging. It uses a linear accelerator to deliver high-dose radiation to the tumour with sub-millimetre precision," said P ShivaKumar, Managing Director, Indraprastha Apollo Hospitals.
"With the most recent introduction of Radixact X9, radiation oncology has reached a new horizon in the race of effective curative treatment for cancer. Large field size can be targeted at once. 1.35 cms of length can be targeted without repositioning the machine," ShivaKumar added.
( With inputs from IANS )